Skip to Content
Find More Like This
Return to Search

Dual chain synthetic heparin-binding growth factor analogs

United States Patent

7,598,224
October 6, 2009
View the Complete Patent at the US Patent & Trademark Office
Brookhaven National Laboratory - Visit the Office of Technology Commercialization and Partnerships Website
The invention provides synthetic heparin-binding growth factor analogs having two peptide chains each branched from a branch moiety, such as trifunctional amino acid residues, the branch moieties separated by a first linker of from 3 to about 20 backbone atoms, which peptide chains bind a heparin-binding growth factor receptor and are covalently bound to a non-signaling peptide that includes a heparin-binding domain, preferably by a second linker, which may be a hydrophobic second linker. The synthetic heparin-binding growth factor analogs are useful as pharmaceutical agents, soluble biologics or as surface coatings for medical devices.
Zamora; Paul O. (Gaithersburg, MD), Pena; Louis A. (Poquott, NY), Lin; Xinhua (Plainview, NY)
BioSurface Engineering Technologies, Inc. (Rockville, MD)
11/ 065,970
20050222394
February 24, 2005
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT This invention was made with United States Government support under contract number DE-AC02-98CH10886, awarded by the U.S. Department of Energy. The United States Government has certain rights in the invention.